Maternal cardiac risks in pre-eclamptic patients

References

• Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005;308:1592–1594.
   PubMed Web of Science ®Google Scholar
• Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2002;87:1–22.
   Google Scholar
• Helewa ME, Burrows RF, Smith J, Williams K, Brain P, Rabkin SW. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ 1997;157:715–725.
   PubMed Web of Science ®Google Scholar
• Australian Society For The Study Of High Blood Pressure In Pregnancy. Management of hypertension in pregnancy: Executive summary. Med J Aust 1993;158:700–702.
   PubMedGoogle Scholar
• Sekiba K, Yoshioka T. Changes of lipid peroxidation and superoxide dismutase activity in the human placenta. Am J Obstet Gynecol 1979;135:368–371.
   PubMed Web of Science ®Google Scholar
• Brown MA, Buddle ML. Hypertension in pregnancy: maternal and fetal outcomes according to laboratory and clinical features. Med J Aust 1996;165:360–365.
   PubMed Web of Science ®Google Scholar
• Nabatian S, Quinn P, Brookfield L, Lakier J. Acute coronary syndrome and preeclampsia. Obstet Gynecol 2005;106:1204–1206.
   PubMedGoogle Scholar
• Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr, Doll R. Mortality from smoking worldwide. Br Med Bull 1996;52:12–21.
   PubMed Web of Science ®Google Scholar
• Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997;349:1269–1276.
   PubMed Web of Science ®Google Scholar
• LaRosa JC. Triglycerides and coronary risk in women and the elderly. Arch Intern Med 1997;157:961–968.
   PubMed Web of Science ®Google Scholar
• Roeters van Lennep JE, Westerveld HT, Erkelens DW, van der Wall EE. Risk factors for coronary heart disease: implications of gender. Cardiovasc Res 2002;53:538–549.
   PubMed Web of Science ®Google Scholar
• Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF. A potential basis for the thrombotic risks associated with lipoprotein(a). Nature 1989;339:301–303.
   PubMed Web of Science ®Google Scholar
• McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987;330:132–137.
   PubMed Web of Science ®Google Scholar
• Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986;256:2540–2544.
   PubMed Web of Science ®Google Scholar
• Armstrong VW, Cremer P, Eberle E, Manke A, Schulze F, Wieland H, Kreuzer H, Seidel D. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis 1986;62:249–257.
   PubMed Web of Science ®Google Scholar
• Memon L, Spasojevic-Kalimanovska V, Bogavac-Stanojevic N, Kalimanovska-Ostric D, Jelic-Ivanovic Z, Spasic S, Topic A. Association of C-reactive protein with the presence and extent of angiographically verified coronary artery disease. Tohoku J Exp Med 2006;209:197–206.
   PubMedGoogle Scholar
• Belaia OL, Fedorova NV. [Study of serum levels of homocystein, lipids and their peroxidation products in patients with coronary heart disease]. Klin Med (Mosk) 2005;83:30–33.
   PubMedGoogle Scholar
• Bökenkamp A, Herget-Rosenthal S, Bökenkamp R. Cystatin C, kidney function and cardiovascular disease. Pediatr Nephrol 2006;21:1223–1230.
   PubMed Web of Science ®Google Scholar
• Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999;13:9–22.
   PubMed Web of Science ®Google Scholar
• Chamy VM, Lepe J, Catalán A, Retamal D, Escobar JA, Madrid EM. Oxidative stress is closely related to clinical severity of pre-eclampsia. Biol Res 2006;39:229–236.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672–683.
   PubMed Web of Science ®Google Scholar
• Khan F, Belch JJ, MacLeod M, Mires G. Changes in endothelial function precede the clinical disease in women in whom preeclampsia develops. Hypertension 2005;46:1123–1128.
   PubMed Web of Science ®Google Scholar
• Soleymanlou N, Jurisica I, Nevo O, Ietta F, Zhang X, Zamudio S, Post M, Caniggia I. Molecular evidence of placental hypoxia in preeclampsia. J Clin Endocrinol Metab 2005;90:4299–4308.
   PubMed Web of Science ®Google Scholar
• Worthley SG, Osende JI, Helft G, Badimon JJ, Fuster V. Coronary artery disease: pathogenesis and acute coronary syndromes. Mt Sinai J Med 2001;68:167–181.
   PubMedGoogle Scholar
• Griendling KK, Alexander RW. Oxidative stress and cardiovascular disease. Circulation 1997;96:3264–3265.
   PubMed Web of Science ®Google Scholar
• Khoo JC, Miller E, McLoughlin P, Steinberg D. Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis 1988;8:348–358.
   PubMedGoogle Scholar
• Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, Faas FH, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999;341:410–418.
   PubMed Web of Science ®Google Scholar
• Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM Jr. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986;74:758–765.
   PubMed Web of Science ®Google Scholar
• Djurovic S, Berg K. Epidemiology of Lp(a) lipoprotein: its role in atherosclerotic/thrombotic disease. Clin Genet 1997;52:281–292.
   PubMedGoogle Scholar
• Ingec M, Borekci B, Kadanali S. Elevated plasma homocysteine concentrations in severe preeclampsia and eclampsia. Tohoku J Exp Med 2005;206:225–231.
   PubMedGoogle Scholar
• Piñón P, Kaski JC. [Inflammation, atherosclerosis and cardiovascular disease risk: PAPP-A, Lp-PLA2 and cystatin C. New insights or redundant information?]. Rev Esp Cardiol 2006;59:247–258.
   PubMedGoogle Scholar
• Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001;323:1213–1217.
   PubMed Web of Science ®Google Scholar
• Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 2002;325:157–160.
   PubMed Web of Science ®Google Scholar
• Sattar N, Gaw A, Packard CJ, Greer IA. Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre-eclampsia. Br J Obstet Gynaecol 1996;103:614–620.
   PubMedGoogle Scholar
• Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499–506.
   PubMed Web of Science ®Google Scholar
• Knock GA, Poston L. Bradykinin-mediated relaxation of isolated maternal resistance arteries in normal pregnancy and preeclampsia. Am J Obstet Gynecol 1996;175:1668–1674.
   PubMed Web of Science ®Google Scholar
• Bayhan G, Koçyigit Y, Atamer A, Atamer Y, Akkus Z. Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia. Gynecol Endocrinol 2005;21:1–6.
   PubMed Web of Science ®Google Scholar
• Craici I, Wagner S, Garovic VD. Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test? Ther Adv Cardiovasc Dis 2008;2:249–259.
   PubMedGoogle Scholar